Shirley H. Lomeli

Also affiliated with University of California, Los Angeles

Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy”.

Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.07.023

N/A

3.9DataRank · unranked

135 citations

Sixue Liu, Zhentao Yang, Alain P. Algazi, Shirley H. Lomeli, Yan Wang +16 more

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100426

N/A

3.2DataRank · unranked

99 citations

Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan M. Wyatt +21 more

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100411

N/A

1.9DataRank · unranked

57 citations

Hannah M. Knochelmann, Shirley H. Lomeli, Aayoung Hong, Mary S. Richardson, Zhentao Yang +14 more

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Cancer(2024)10.1002/cncr.35200

N/A

0.612DataRank · unranked

12 citations

James Moon, Christopher D. Lao, Bartosz Chmielowski, Kari Kendra, Karl D. Lewis +12 more

Multi-organ landscape of therapy-resistant melanoma

Nature Medicine(2023)10.1038/s41591-023-02304-9

N/A

0DataRank · unranked

31 citations

Prashanthi Dharanipragada, Shirley H. Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang +9 more

Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma

UNC Libraries(2020)10.17615/73y8-rn80

N/A

0DataRank · unranked

7 citations

Gatien Moriceau, Robert Damoiseaux, Roger S. Lo, Lu Sun, Aayoung Hong +5 more

Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors

Immunity(2025)10.1016/j.immuni.2025.10.001

N/A

0DataRank · unranked

3 citations

Shiyue Yang, Zhentao Yang, Jianfeng Fan, Shirley H. Lomeli, Prashanthi Dharanipragada +12 more

Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0936

N/A

0DataRank · unranked

78 citations

Jenna K. Minami, Arthur Huang, Siavash R. Dehkordi, Shirley H. Lomeli, Jens Luebeck +26 more

Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH

Nature Genetics(2022)10.1038/s41588-022-01190-0

N/A

0DataRank · unranked

125 citations

Jens Luebeck, Siavash R. Dehkordi, Caterina I. Colón, Rui Li, Ivy Tsz-Lo Wong +21 more

Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1463

N/A

0DataRank · unranked

39 citations

Yan Wang, Sixue Liu, Weixian Deng, Shirley H. Lomeli, Gatien Moriceau +4 more